Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT05714605

Implementation and Evaluation of A Health Innovation to Support Medicaid-Insured Individuals Following Hospitalization

The goal of this stepped wedge pragmatic trial is to compare referral patterns and post discharge outcomes in Medicaid insured individuals discharge following a hospitalization]. The aims are to 1) evaluate the implementation of the THRIVE clinical pathway, including feasibility, appropriateness, and acceptability and 2) examine referral patterns, 30- day readmission and Emergency Department (ED) utilization patterns for participants who receive THRIVE support services. During hospitalization participants will receive a referral to home care services and will be seen by a home care nurse within 48 hours following discharge. A discharging physician or Advanced Practice Provider will maintain clinical oversight for 30 days or until the patient sees primary care provider or specialist. A Care Coordination Team conducts weekly case conferences to ensure social and health needs are being addressed for 30 days post-discharge. Researchers will compare Medicaid insured patients discharged during the study, to those receiving usual care to determine if there are differences in post-acute utilization outcomes.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pennsylvania Hospital

Philadelphia, Pennsylvania, 19107, United States

About this study

This is a prospective single site Type 1 hybrid effectiveness-implementation parallel mixed methods (QUANT + qual) quasi-experimental study. This study design involves simultaneous collection and analysis of quantitative and qualitative data, giving priority weight to the quantitative data to evaluate program referrals, outcomes, and program fidelity, while qualitative data will evaluate process through detailed descriptions of perspectives of barriers and facilitators faced by health care providers in implementing the THRIVE intervention. Qualitative interviews will also assess stakeholder perspectives of the value of the intervention in addressing health inequities among Medicaid insured individuals cared for in the acute and home care settings. Nesting the qualitative interview within a single-site randomized trial of a the THRIVE intervention will allow us to determine whether the intervention improved primary outcomes (referrals to homecare, 30-day readmission, ED utilization, connection to PCP) and to identify professional and organizational barriers to implementation. Combining these insights with that of effectiveness outcome date will allow consideration for meaningful contextual factors that are viewed as critical to the implementation of THRIVE and subsequent outcomes. Our stepped wedge design with include a randomized roll-out to case managers at Pennsylvania Hospital and the study will be carried out over 18 months. To begin, 5 case managers will be randomized to receive training on the THRIVE clinical pathway. Following training they will be invited to begin offering referrals to the THRIVE clinical pathway. After 2 months the remaining 4 case managers will be trained on the THRIVE intervention and will be able to begin submitting referrals.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medicaid insured
  • Residing in the state of Pennsylvania
  • Experienced a hospitalization at study hospital
  • Agrees to home care at partner home care setting.

Exclusion criteria

  • Individuals under age 18

Treatment and study plan

Thrive Intervention

Behavioral

The THRIVE Clinical Pathway is a standardized transitional care clinical pathway that supports Medicaid insured or Medicaid eligible individuals following hospitalization.

Primary outcomes

  1. Rates of Referrals to Homecare

    Time frame: Through study completion, an average of 18 months

    We will evaluate changes in home care referrals between case managers exposed to the intervention compared to those who were not.

  2. Rates of Readmissions

    Time frame: 30 days following hospital discharge

    We will evaluate the rate of readmissions over the course of the study for THRIVE participants compared to those receiving usual care.

  3. Rates of Emergency Department Visit

    Time frame: 30 days following hospital discharge

    We will evaluate the rate of ED visits over the course of the study for THRIVE participants compared to those receiving usual care.

  4. Primary Care or Specialist Visit

    Time frame: 30 Days following hospital discharge

    We will compare the rates of primary care provider and specialist visits within 30 days following discharge compared to those receiving usual care.

Secondary outcomes

  1. Feasibility, Acceptability, Appropriateness, Workload

    Time frame: Through study completion, an average of 18 months

    We will conduct interviews of clinicians at the conclusion of the study to gather perceptions of the THRIVE clinical pathway and facilitators and barriers to engaging with the intervention.

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • Rita & Alex Hillman Foundation

Registry information

Official study title

Implementation and Evaluation of THRIVE: A Health Innovation to Support Care Transitions for Medicaid-Insured Individuals Following Hospitalization

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Feb 6, 2023
Registry last updated
Jul 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.